VÉSALE BIOSCIENCE
Press
O.A.G. (UK) 
O.A.G. (UK)
Vésale Bioscience, a pioneer in the development of innovative, personalized and sustainable phage-based therapy solutions for tackling superbugs and antimicrobial resistance.
L’Écho
L’Écho
Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT
La Libre
La Libre
Vésale Bioscience enters into an innovative and ambitious collaboration with the Belgian Army
L’Écho
L’Écho
Vésale Bioscience raises a first tranche of €3 million: in preparation for its IPO, which has been brought forward to the end of 2022, Vésale Bioscience has raised a first tranche of funds from private investors.
